 CHATHAM, N.J., Jan. 03, 2023 GLOBE NEWSWIRE -- Tonix Pharmaceuticals Holding Corp. Nasdaq: TNXP, a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals, will present at Biotech Showcase 2023 being held January 9-11, 2023, at the Hilton San Francisco Union Square. 